opioid-risk-assessment

You can calculate opioid MME and ORT scores by aggregating active prescriptions, conditions, and observations from FHIR resources to synthesize a comprehensive risk assessment with accurate MME calculation and gender-specific ORT scoring.

A comprehensive opioid risk assessment includes aggregating active opioid prescriptions, ORT factors, UDS and PDMP monitoring data, MME calculation, and clear risk stratification with actionable safety recommendations for chronic or acute pain management.

FHIR resources can be used for pre-prescription screening and ongoing monitoring by aggregating active medications, conditions, and observations to evaluate risk before initiating opioid therapy and reassessing risk with dose changes or new substances.

You can determine when naloxone co-prescribing is indicated by generating an opioid risk assessment that flags safety thresholds based on MME calculations, ORT scoring, and monitoring data, producing actionable naloxone planning guidance.

The opioid risk assessment supports PDMP and UDS references by incorporating monitoring data from FHIR resources to synthesize comprehensive risk stratification and adherence evaluation for ongoing monitoring workflows.